(732) 390-7750
Contact Us
Payments
Patient Portal
Make A Referral
Start typing & press "Enter" or "ESC" to close
Appointments
Locations
Care Team
Medical Oncologists
Radiation Oncologists
Breast Surgeons
Advanced Practice Providers
Pharmacists
Social Workers
Palliative Team
Research Team
Full Care Team
For Patients
SPECIALTIES & SERVICES
Medical Oncology
Hematology
Breast Care
Radiation Oncology
The Science of Treatment
Deep Inspiration Breath Hold (DIBH)
Leading-Edge HDR & LDR Brachytherapy
SpaceOAR Hydrogel
Intensity Modulated Radiation Therapy (IMRT)
Accelerated Partial Breast Irradiation (APBI)
Prone Breast Radiation Therapy
Prostate Seed Implantation
Proton Therapy
Skin Cancer Treatment
Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery
Theranostics
TomoTherapy
Osteoarthritis/Radiation
Infusion
Pharmacy
Research
Clinical Trials
Research News
Patient Experience
Patient Stories
Awards/Recognition
Magazine Archives
Blogs
News & Events
Patient Portal
Payments
Support and Wellness Progams
Palliative & Supportive Care
Social Work
Nutrition
Tobacco Cessation
Upcoming Programs
Past Programs
Support Groups
Billing & Insurance
Financial Assistance
Transportation
FAQ & Useful Links
Cancers & Blood Disorders
Research
Clinical Trials
Research News
About
Blogs
About Us
Our Care Team
Our Leadership
News & Events
Careers
ASHORE Program
A Phase 1, First-in-Human Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Participants With Advanced Breast Cancer
Condition: Breast Cancer
Go To Trial Homepage
